No control over the Freezing?
Freezing & thawing in static and blast freezers is uncontrollable. It takes a long time and leads to reduced product quality due to the effects of cryoconcentration. Plate-based freezers give you back full control over the freezing rate - whatever is best for your product. Be One Step Ahead and cool down with best freezing results.
Further assets:
The One Process Solution for Bulk Drug Substances
Advanced Fluid & Cold Chain Management for large volumes of drug substances, including robust protection for single-use bags, automated aseptic aliquoting, controlled plate-based freezing & thawing, ultra-cold storage and smart cold chain shipping.
Watch video: The One Process Solution for Bulk Drug Substances - YouTube
"Bestcellers“: Controlled Filling & Freezing of Cells
What is needed are modular and controllable technologies that support biopharmaceutical companies to cope with process versatility. The adaptability of process solutions to different requirements and scenarios while complying with current good manufacturing practices (cGMP) will meet the needs of biomanufacturing companies along the journey from drug development to commercialization. In the end, state-of-the-art filling and freezing technologies significantly improve cell viability.
“How controlled freezing becomes a reality”
Controlling the freezing behavior of drug substance is the ultimate goal in pharmaceutical manufacturing. It opens doors to process reproducibility, consistent quality of the final drug product by maintaining uniform conditions for the biopharmaceuticals during freezing and consequently for frozen storage and shipment. In a comprehensive study the impact of ice front growth speed on scalability of freezing protein solutions has been evaluated throughout different scales, by reaching high product homogeneity during freezing and by maintaining highest protein activity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
